Effects of glucagon‐like peptide‐1 receptor agonists on glycated haemoglobin and continuous glucose monitoring metrics as adjunctive therapy to insulin in adults with type 1 diabetes: A meta‐analysis of randomized controlled trials

Documenti analoghi

• Effect of tirzepatide on the risk of diabetic retinopathy in type 2 diabetes
  di: Djordje S. Popovic, et al.
  Pubblicazione: (2024)
• And the Dog Was Barking: Transforming Quality of Life in Diabetes Through Innovative Hypoglycemia Detection
  di: Theocharis Koufakis, et al.
  Pubblicazione: (2025)
• Has the time come for a remission definition in type 1 diabetes? A functional perspective
  di: Djordje S. Popovic, et al.
  Pubblicazione: (2026)
• Current treatment guidelines and glycated haemoglobin goals for type 2 diabetes: Which patients are most likely to benefit from fixed‐ratio basal insulin glucagon‐like peptide‐1 receptor agonist combinations?
  di: Kevin Cowart, et al.
  Pubblicazione: (2025)
• Use of continuous glucose monitoring when initiating glucagon‐like peptide ‐ 1 receptor agonist therapy in insulin‐treated diabetes
  di: Irl B. Hirsch, et al.
  Pubblicazione: (2024)